Shogun Organics, a part of Safex Chemicals Group, developed renofluthrin, India’s first indigenously developed and patented mosquito repellent molecule. The breakthrough comes after a decade of intensive research and development, representing a noticeable advancement in the country’s capabilities in molecular research.
Neeraj Jindal, Group Director, Safex Chemicals Group said, “Renofluthrin is not just a new product, but a testament to India’s growing prowess in molecular development. After ten years of dedicated scientific work and substantial investment, we are proud to introduce a solution that makes India self-reliant in mosquito control technology. Shogun stays committed to invest in R&D to bring more such products in the future”.
Renofluthrin promises to be twice as effective as existing formulations in liquid vaporizer formats currently available in the Indian market. Notably, it continues to repel mosquitoes for up to two hours after being switched off, offering extended protection to users.
As per the press release, the research and development of renofluthrin was carried out in partnership with Godrej Consumer Products Limited (GCPL), combining Shogun’s expertise in molecule development with GCPL’s market reach. Shogun Organics holds the patent for renofluthrin and has partnered exclusively with GCPL for its use in India.
Jindal added, “Renofluthrin has demonstrated efficacy against multiple mosquito species, including Anopheles, Aedes, and Culex, which are responsible for spreading diseases like malaria and dengue. The molecule has undergone rigorous testing and received approval from the Central Insecticide Board and Registration Committee (CIB&RC), underscoring its safety and effectiveness”.
